Literature DB >> 29531031

Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes.

Eugenia Tomasella1, Lucila Bechelli1, Mora Belén Ogando2, Camilo Mininni1, Mariano N Di Guilmi3, Fernanda De Fino4, Silvano Zanutto1, Ana Belén Elgoyhen3, Antonia Marin-Burgin2, Diego M Gelman5.   

Abstract

Excessive dopamine neurotransmission underlies psychotic episodes as observed in patients with some types of bipolar disorder and schizophrenia. The dopaminergic hypothesis was postulated after the finding that antipsychotics were effective to halt increased dopamine tone. However, there is little evidence for dysfunction within the dopaminergic system itself. Alternatively, it has been proposed that excessive afferent activity onto ventral tegmental area dopaminergic neurons, particularly from the ventral hippocampus, increase dopamine neurotransmission, leading to psychosis. Here, we show that selective dopamine D2 receptor deletion from parvalbumin interneurons in mouse causes an impaired inhibitory activity in the ventral hippocampus and a dysregulated dopaminergic system. Conditional mutant animals show adult onset of schizophrenia-like behaviors and molecular, cellular, and physiological endophenotypes as previously described from postmortem brain studies of patients with schizophrenia. Our findings show that dopamine D2 receptor expression on parvalbumin interneurons is required to modulate and limit pyramidal neuron activity, which may prevent the dysregulation of the dopaminergic system.

Entities:  

Keywords:  DRD2; deletion; mouse; parvalbumin; psychosis

Mesh:

Substances:

Year:  2018        PMID: 29531031      PMCID: PMC5879696          DOI: 10.1073/pnas.1719897115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Input normalization by global feedforward inhibition expands cortical dynamic range.

Authors:  Frédéric Pouille; Antonia Marin-Burgin; Hillel Adesnik; Bassam V Atallah; Massimo Scanziani
Journal:  Nat Neurosci       Date:  2009-11-01       Impact factor: 24.884

Review 2.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

3.  Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

Authors:  S B Floresco; C L Todd; A A Grace
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

4.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Authors:  Y Okubo; T Suhara; K Suzuki; K Kobayashi; O Inoue; O Terasaki; Y Someya; T Sassa; Y Sudo; E Matsushima; M Iyo; Y Tateno; M Toru
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

5.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

Authors:  S Akbarian; J J Kim; S G Potkin; J O Hagman; A Tafazzoli; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1995-04

6.  Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

Authors:  B K Lipska; G E Jaskiw; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1993-08       Impact factor: 7.853

7.  Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.

Authors:  Mia Thompson; Cynthia Shannon Weickert; Eugene Wyatt; Maree J Webster
Journal:  J Psychiatr Res       Date:  2009-03-24       Impact factor: 4.791

8.  D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex.

Authors:  Kuei Y Tseng; Patricio O'Donnell
Journal:  Synapse       Date:  2007-10       Impact factor: 2.562

9.  Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions.

Authors:  Stan B Floresco
Journal:  Front Neurosci       Date:  2013-04-19       Impact factor: 4.677

10.  Age-dependent regulation of synaptic connections by dopamine D2 receptors.

Authors:  Jie-Min Jia; Jun Zhao; Zhonghua Hu; Daniel Lindberg; Zheng Li
Journal:  Nat Neurosci       Date:  2013-10-13       Impact factor: 24.884

View more
  11 in total

1.  Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic Treatment.

Authors:  Esther M Blessing; Vishnu P Murty; Botao Zeng; Jijun Wang; Lila Davachi; Donald C Goff
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  Estrogen-related Receptor Alpha (ERRα) is Required for PGC-1α-dependent Gene Expression in the Mouse Brain.

Authors:  L J McMeekin; K L Joyce; L M Jenkins; B M Bohannon; K D Patel; A S Bohannon; A Patel; S N Fox; M S Simmons; J J Day; A Kralli; D K Crossman; R M Cowell
Journal:  Neuroscience       Date:  2021-10-11       Impact factor: 3.708

3.  Characterization of Hemodynamic Alterations in Schizophrenia and Bipolar Disorder and Their Effect on Resting-State fMRI Functional Connectivity.

Authors:  Wenjing Yan; Lena Palaniyappan; Peter F Liddle; D Rangaprakash; Wei Wei; Gopikrishna Deshpande
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

4.  A Novel Biomarker Renalase and Its Relationship with its Substrates in Schizophrenia.

Authors:  Zekiye Catak; Esra Kocdemir; Kader Ugur; Meltem Yardim; İbrahim Sahin; Hilal Kaya; Suleyman Aydin
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

Review 5.  Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments.

Authors:  Sebastiano Alfio Torrisi; Samuele Laudani; Gabriella Contarini; Angelina De Luca; Federica Geraci; Francesca Managò; Francesco Papaleo; Salvatore Salomone; Filippo Drago; Gian Marco Leggio
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-05

6.  Retrograde Labeling Illuminates Distinct Topographical Organization of D1 and D2 Receptor-Positive Pyramidal Neurons in the Prefrontal Cortex of Mice.

Authors:  Sara M Green; Sanya Nathani; Joseph Zimmerman; David Fireman; Nikhil M Urs
Journal:  eNeuro       Date:  2020-10-26

7.  Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex.

Authors:  Gloria S Lee; Devon L Graham; Brenda L Noble; Taylor S Trammell; Deirdre M McCarthy; Lisa R Anderson; Marcelo Rubinstein; Pradeep G Bhide; Gregg D Stanwood
Journal:  Front Behav Neurosci       Date:  2022-01-13       Impact factor: 3.558

8.  Activation of Dopamine 4 Receptor Subtype Enhances Gamma Oscillations in Hippocampal Slices of Aged Mice.

Authors:  Yuan Wang; Yi-Kai Jin; Tie-Cheng Guo; Zhen-Rong Li; Bing-Yan Feng; Jin-Hong Han; Martin Vreugdenhil; Cheng-Biao Lu
Journal:  Front Aging Neurosci       Date:  2022-03-16       Impact factor: 5.750

Review 9.  Astrocytic Regulation of Glutamate Transmission in Schizophrenia.

Authors:  Yu-Ying Mei; Dong Chuan Wu; Ning Zhou
Journal:  Front Psychiatry       Date:  2018-11-06       Impact factor: 4.157

10.  Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.

Authors:  Michelle Kokkinou; Elaine E Irvine; David R Bonsall; Sridhar Natesan; Lisa A Wells; Mark Smith; Justyna Glegola; Eleanor J Paul; Kyoko Tossell; Mattia Veronese; Sanjay Khadayate; Nina Dedic; Seth C Hopkins; Mark A Ungless; Dominic J Withers; Oliver D Howes
Journal:  Mol Psychiatry       Date:  2020-05-07       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.